Product image of Metronidazol Viaflo Baxter (Metronidazole) supplied by GNH India

Metronidazol Viaflo Baxter

Active Ingredient:
Metronidazole
Origin:
EU

Metronidazol Viaflo Baxter (Metronidazole)

Metronidazole, the active ingredient in Metronidazol Viaflo Baxter, is a Nitroimidazole antibiotic presented as an injectable solution for intravenous use. It treats severe infections caused by susceptible anaerobic bacteria and certain protozoa in adult and pediatric patients.
GNH India supplies Metronidazol Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Baxter Medical Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metronidazole is employed for infections where anaerobic bacteria play a key pathogenic role.

  • Intra‑abdominal infections: eradicates mixed aerobic‑anaerobic flora to control peritonitis and postoperative sepsis.
  • Bacterial sepsis due to anaerobes: provides rapid systemic coverage in critically ill patients.
  • Pelvic inflammatory disease: eliminates anaerobic organisms responsible for tubo‑ovarian abscesses.
  • Bacterial meningitis (anaerobic etiology): penetrates the cerebrospinal fluid to treat resistant strains.
  • Necrotizing skin and soft‑tissue infections: targets deep‑seated anaerobes in fasciitis and gangrene.

How It Works

  • Metronidazole is reduced within susceptible microorganisms, generating reactive nitro radicals that damage DNA and inhibit nucleic acid synthesis. This leads to strand breakage and cell death, selectively affecting anaerobic bacteria and protozoa while sparing most human cells.

Side Effects

Metronidazole may cause a range of adverse reactions.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Metallic taste: transient metallic sensation in the mouth.
  • Headache: occasional dull or throbbing pain.
  • Diarrhoea: loose stools, sometimes watery.
  • Abdominal pain: cramping or discomfort.
  • Rash: mild skin erythema or itching.

Serious or Rare Side Effects

  • Seizures: neurologic events requiring immediate care.
  • Peripheral neuropathy: tingling or numbness in extremities.
  • Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.
  • Anaphylaxis: acute allergic reaction with airway compromise.
  • Hepatotoxicity: elevated liver enzymes or jaundice.
  • Blood dyscrasias: neutropenia, thrombocytopenia, or aplastic anaemia.

Precautions & Warnings

Metronidazol Viaflo Baxter requires careful clinical consideration.

  • Renal impairment: adjust dosing in patients with reduced kidney function.
  • Hepatic dysfunction: monitor liver enzymes and consider dose modification.
  • Alcohol consumption: avoid due to disulfiram‑like reaction causing flushing and tachycardia.
  • Pregnancy: category unknown; use only if potential benefit outweighs risk.
  • Neonates: avoid in premature infants because of reduced metabolic capacity.
  • Store at ambient temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Metronidazol Viaflo Baxter can interact with several medicines.

Major Interactions (Avoid)

  • Alcohol: may cause severe disulfiram‑like reaction.
  • Warfarin: potentiates anticoagulant effect, increasing bleeding risk.
  • Lithium: can raise lithium serum levels, leading to toxicity.
  • Cyclosporine: may increase cyclosporine concentrations.
  • Phenytoin: reduces metronidazole levels, compromising efficacy.

Moderate Interactions (Monitor Closely)

  • Cimetidine: may increase metronidazole plasma concentration.
  • Oral contraceptives: possible reduction in contraceptive effectiveness.
  • Carbamazepine: may lower metronidazole levels.
  • Rifampin: can decrease metronidazole exposure.
  • Theophylline: may raise theophylline levels, requiring monitoring.

Frequently Asked Questions

Metronidazol Viaflo Baxter is an intravenous formulation of metronidazole used to treat severe infections caused by anaerobic bacteria and certain protozoa. It is commonly employed in hospital settings for intra‑abdominal sepsis, pelvic inflammatory disease, bacterial meningitis of anaerobic origin, and necrotizing skin and soft‑tissue infections.

Metronidazole enters susceptible microorganisms and is reduced by intracellular electron‑transport proteins. This reduction creates reactive nitro radicals that bind to DNA, causing strand breakage and inhibition of nucleic acid synthesis, ultimately leading to bacterial or protozoal cell death while sparing most human cells.

The dosage of Metronidazol Viaflo Baxter is individualized by the prescribing clinician based on infection type, severity, patient weight, renal and hepatic function, and other clinical factors. No fixed regimen is provided here; the prescriber sets the appropriate dose and infusion rate.

Metronidazole’s pregnancy category is listed as unknown, and safety data are limited. It should be used only when the potential benefit justifies any possible risk to the fetus. Breastfeeding mothers should consult a healthcare professional, as the drug can be excreted in milk.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Metronidazol Viaflo Baxter belongs to the nitroimidazole class, offering rapid anaerobic coverage that many beta‑lactams lack. Compared with clindamycin, it has a broader spectrum against protozoa and fewer drug‑induced liver enzyme elevations, though both share risks of gastrointestinal upset. Choice depends on pathogen susceptibility and patient factors.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from direct sunlight, moisture, and extreme temperature fluctuations. Do not freeze. Follow aseptic techniques when preparing the infusion to maintain sterility.

Metronidazol Viaflo Baxter is given by intravenous infusion. The solution is typically diluted in compatible IV fluids and infused over 30–60 minutes, depending on the prescribed dose and patient tolerance. Administration should be performed by qualified healthcare personnel in a clinical setting.

Serious adverse events include seizures, peripheral neuropathy, severe skin reactions such as Stevens‑Johnson syndrome, anaphylaxis, hepatotoxicity, and hematologic abnormalities like neutropenia or aplastic anemia. Prompt medical evaluation is required if any of these symptoms develop during therapy.

Patients with a known hypersensitivity to metronidazole or other nitroimidazoles should avoid the product. It is also contraindicated in premature neonates (≤ 28 days) and should be used with caution in individuals with severe hepatic or renal impairment, unless dose adjustments are made.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.